Apr 22, 2024
AMD is thrilled to share what we’ve learned so far
from our HEADS Registry!
Molly O'Brien goes over the exclusive new data in this Migraine
Minute News Update.
The HEADS Registry serves as a crucial resource for researchers and
clinicians. It’s not too late to share your experience, by doing
so, you can help pave...
Apr 5, 2024
Obesity is often connected with an increase in migraine frequency, severity and disability.
In this Migraine Minute News Update, Molly O'Brien gives details on what we’re learning about one MAB drug and its effectiveness in people with migraine and comorbid obesity.
Read more here: https://bit.ly/3ONRu6m
Mar 22, 2024
New results from the OVERCOME study, published in Neurology, Found that just over 31 percent of people living with migraine often or very often feel stigmatized. Molly O'Brien will fill you in on the details in this Migraine Minute News Update.
Mar 11, 2024
Nerivio becomes the first drug-free Migraine Treatment to
Receive Commercial Insurance Coverage in the US. Molly
O'Brien explains in this Migraine Minute News Update.
Read more here: https://bit.ly/3T6lKvL
Feb 23, 2024
We know Migraine and ADHD are comorbid, but there is still a lot left to learn about how they are connected. @Molly O’Brien will fill you in on new research that explores ADHD symptoms in people with migraine.
Sources: